Your session is about to expire
← Back to Search
PEG IFN-alfa-2a for Hepatitis Delta (D-LIVR Trial)
D-LIVR Trial Summary
This trial will compare two hepatitis C treatments, one with and one without a certain drug. The treatments will be evaluated based on their ability to suppress the virus and normalize alanine aminotransferase levels.
- Hepatitis Delta
D-LIVR Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.D-LIVR Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Did the FDA clear PEG IFN-alfa-2a for use?
"PEG IFN-alfa-2a is in Phase 3 clinical trials, so there is some data indicating its efficacy and multiple rounds of data affirming its safety. Our team at Power rated PEG IFN-alfa-2a's safety as a 3."
Are there any vacant slots in this ongoing research project?
"The study, which was posted on December 1st, 2018, as indicated on clinicaltrials.gov, is looking for participants. The 9/30/2021 update was the most recent one as of now."
Are there any other similar clinical trials that have used PEG IFN-alfa-2a?
"The first study involving PEG IFN-alfa-2a was completed in 1998 at Nova Scotia Cancer Centre. As of now, 942 studies have been completed with 53 more ongoing. The majority of these ongoing studies are located in Los Angeles, California."
Are there any other hospitals or care facilities conducting this research project within the state?
"This study is being conducted by Ruane Clinical Research Group Inc. at their location in Los Angeles, California. Additionally, University of Rochester Medical Center in Rochester, New york and Central Sooner Research in Norman, Oklahoma are a few of the other 22 sites where this trial is taking place."
PEG IFN-alfa-2a is typically used to treat which conditions?
"PEG IFN-alfa-2a is a medication used to treat malignancies, hematologic disorders, hutchinson-gilford progeria syndrome, and non-hodgkin's lymphoma, lymphoma, and follicular lymphoma."
How many total people are included in this experiment?
"400 individuals that fit the bill are needed for this clinical trial. If you are eligible and interested, you can take part in this research out of different locations such as Ruane Clinical Research Group Inc. in Los Angeles, California or University of Rochester Medical Center in Rochester, New york."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger